Skip to content

NMRA - Neumora Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchN

Neumora Therapeutics, Inc.

NMRA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

N

NMRANeumora Therapeutics, Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $3.65
52-wk low: $0.83
Prev close: $2.50
Mkt cap: $308.1M
Beta: 2.78
P/B: 6.9x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$32.0M

TS
Two Sigma
Q2 2026 13F
$3.8M
position
JS
Jim Simons
Q2 2026 13F

Earnings

Reported Aug 5, 2026

Earnings landed in line with what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $308M

Valuation

P/B6.92

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: NMRA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $308.15M
Beta: 2.78

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-187.1%

$2.1M

position

MW

Marshall Wace

Q2 2026 13F

$1.5M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for NMRA

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.23+0.0%

-$0.23 expected

Next report

What the street expects next

EPS expected

-$0.20

-$0.21 to -$0.19

Revenue expected

$0.00

9 analysts

Last 30 days

1up1down

Split both ways

Estimate drift

+0.01

Change in 30 days

-187.1%

ROA-73.9%

Growth

Beta2.78